_a-tale-of-salt-and-sugar-sglt2-inhibitors-in-cardiovascular-disease-preview-1.jpg "A Tale of Salt and Sugar: SGLT2 Inhibitors in Cardiovascular Disease from sgkt2 Video Screenshot Preview 1")
Gallery_a-tale-of-salt-and-sugar-sglt2-inhibitors-in-cardiovascular-disease-preview-3.jpg "A Tale of Salt and Sugar: SGLT2 Inhibitors in Cardiovascular Disease from sgkt2 Video Screenshot Preview 3")
Gallery_a-tale-of-salt-and-sugar-sglt2-inhibitors-in-cardiovascular-disease-preview-hqdefault.jpg "A Tale of Salt and Sugar: SGLT2 Inhibitors in Cardiovascular Disease from sgkt2 Video Screenshot Preview hqdefault")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Jump To Video Parts
⏲ Duration: 1 hour 6 minutes 15 seconds
👁 View: 4.1K times
Play Audio:👁 View: 4.1K times
Description:
Emory Cardiology
Emory Cardiology
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_field-notes-ep-19-124-slowing-down-progression-of-ckd-sglt2-inhibitors-with-dr-robert-kossmann.webp "Fresenius Medical Care North America")
⏲ 15 minutes 35 seconds 👁 848
_choosing-sglt2-inhibitors-vs-glp-1-receptor-agonists.webp "Harvard Medical School Continuing Education")
_when-should-we-use-sglt2-inhibitors.webp "The France Foundation")
_sglt2-inhibitors-in-heart-failure-new-analyses-and-recent-updates.webp "Cátedra USC Semergen")
⏲ 1 hour 5 minutes 21 seconds 👁 1.4K
_how-sglt2-inhibitors-protect-the-kidney.webp "Conan Liu, M.D.")
_sglt2-inhibitors-are-associated-with-reduced-cv-disease-in-type-2-diabetes.webp "Mayo Proceedings")
⏲ 5 minutes 7 seconds 👁 151
_9234sglt2-inhibitors-mechanisms-of-behind-the-mortality-benefit9234-presented-by-amy-li.webp "University of Colorado | Department of Medicine")
⏲ 56 minutes 22 seconds 👁 1.1K
_sglt2-inhibitors-explained-in-3-minutes.webp "Drug Matters")
_field-notes-ep-19-124-slowing-down-progression-of-ckd-sglt2-inhibitors-with-dr-robert-kossmann.jpg)
_choosing-sglt2-inhibitors-vs-glp-1-receptor-agonists.jpg)
_when-should-we-use-sglt2-inhibitors.jpg)
_sglt2-inhibitors-in-heart-failure-new-analyses-and-recent-updates.jpg)
_how-sglt2-inhibitors-protect-the-kidney.jpg)
_sglt2-inhibitors-are-associated-with-reduced-cv-disease-in-type-2-diabetes.jpg)
_9234sglt2-inhibitors-mechanisms-of-behind-the-mortality-benefit9234-presented-by-amy-li.jpg)
_sglt2-inhibitors-explained-in-3-minutes.jpg)
![[+]](/images/menu.gif){kind=small}